A cancer drug which received standing ovation from the Global Medical Community is being withheld from NHS breast cancer patients. METUPUK are devastated by NICE decision not to recommend the drug
METUPUK are delighted by the Scottish Medicines Consortium (SMC) acceptance of Enhertu (trastuzumab deruxtecan) for routine use on the NHS. The Scottish Medicines Consortium (SMC) has accepted: Trastuzumab deruxtecan (Enhertu)
METUPUK are delighted for the approval of Trastuzumab deruxtecan (Enhertu) for treating HER2-positive unresectable or metastatic breast cancer in adults who have received one or more prior anti-HER2 based therapies approved for use through the Cancer Drugs Fund in NHS in England.
The Scottish Medicines Consortium (SMC) has approved today:
Trastuzumab deruxtecan (Enhertu) for treating HER2-positive unresectable or metastatic breast cancer in adults who have received two or more prior anti-HER2 based therapies for routine use on the NHS in Scotland.
Tucatinib (Tukysa) with trastuzumab and capecitabine for treating HER2-positive unresectable locally advanced or metastatic breast cancer after two or more anti-HER2 therapies for routine use on the NHS in Scotland.
METUP-UK member Bex Lewis was pleased to be invited to join Will Taylor’s ‘Good Enough’ podcast, off the back of social media content talking about the problematic nature of talking
The article, featuring METUP-UK founder Jo Taylor, starts: Jo Taylor’s situation is something of a double-edged sword. She relies on continuous treatment for secondary breast cancer to maintain a good
Last week METUPUK activist Bex Lewis spoke to Abigail Thomas for the Christian podcast – ‘The Hopeful Activists‘ – around the theme of grief and h0pe within the cancer experience:
Sarah Hughes has written an excellent piece in The Guardian about what it’s like to live with Stage IV cancer during COVID times (including missing out as life ticks away,
METUPUK advocate Emma Robertson spoke with ICR on pricing for cancer drugs, and gave insights into how the process can be sped up, saving more lives. The article covers the
METUPUK member Bex Lewis has loved attending ‘Tech for Good‘ sessions in Manchester for many years (the events started in 2016), and has enjoyed hearing speakers from NHS Digital amongst
